NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-029-1998-0-EP-06 RECOMBINANT ANTI-TUMOR RNASE EP DIV 02078725.5 Abandoned
NCI E-138-1998-0-US-02 Methods and Compositions for DRM, A Secreted Protein with Cell Growth Inhibiting Activity US ORD 09/277,407 Abandoned
NCI E-029-1998-0-CA-11 RECOMBINANAT ANTI-TUMOR RNASE CA DIV 2401916 Abandoned
NCI E-029-1998-0-CA-03 RECOMBINANAT ANTI-TUMOR RNASE CA National Stage 2324646 Abandoned
NCI E-232-1998-0-US-01 Methods for Identifying Modulators of GADD45 Polypeptide Activity US 60/126,069 Abandoned
NIAID E-082-1996-0-US-07 SIMIAN-HUMAN HAV Having a Chimeric 2C Protein US National Stage 09/171,387 6280734 Abandoned PDF
NIAID E-200-1997-0-US-01 Methods of Treating Colitis Using Stat-4 Anti-Sense Oligonucleotides US 60/125,877 Abandoned
NCI E-302-1998-0-US-01 Induction of Antigen-Specific Unresponsiveness by Glioblastoma Culture Supernatant(GCS) US 60/125,996 Abandoned
NCI E-105-1999-0-US-01 Phenylalanine Derivatives US 60/126,047 Abandoned
NCI E-071-1999-0-US-01 Ac-HEHA and Related Compounds, Methods of Synthesis and Methods of Use US 60/125,764 Abandoned
NIAID E-049-1998-0-US-09 3'GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES US National Stage 09/269,367 Abandoned
NIAID E-093-1999-0-AU-08 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B AU National Stage 31095/99 Abandoned
NIAID E-093-1999-0-PCT-02 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B PCT PCT PCT/US1999/006225 Expired
NIAID E-093-1999-0-EP-05 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B EP National Stage 99912799.6 Expired
NIAID E-093-1999-0-KR-07 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B KR National Stage 7010624/2000 Expired
NIAID E-093-1999-0-JP-10 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B JP National Stage 537978/00 Expired
NIAID E-093-1999-0-IL-06 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B IL National Stage 138681 Expired
NIAID E-093-1999-0-CN-04 Mutations Responsible for Attenuation in Measles Virus or Human Respiratory Syncytial Virus Subgroup B CN National Stage 99804382.6 Expired
NCI E-081-1998-2-PCT-01 Cytotoxic Metal Chelators and Methods for Making and Using Same PCT PCT COMB PCT/US1999/005977 Expired
NCI E-081-1998-2-EP-03 CYTOTOXIC METAL CHELATORS AND METHODS FOR MAKING AND USING SAME EP National Stage 99913968.6 Abandoned
NCI E-081-1998-2-JP-02 Tumor Cell Toxicity of a Novel Metal Chelator JP National Stage 2000-536699 Expired
NINDS E-150-1999-0-US-01 Cells, Cell Populations, and Methods of Making and Using Same US 60/124,889 Abandoned
NCI E-125-1999-0-US-01 Adenoviral Vector Expressing A SV40 T Antigen Antisense RNA US 60/124,776 Abandoned
NCCIH E-300-1998-0-US-01 LOW LEVEL EXPOSURE TO EXTRACT OF NEUROTOXIN FOR PROTECTION FROM BRAIN INJURY US ORD 09/271,009 Abandoned
NIAID E-039-1999-0-US-01 A Novel Chimeric Protein for Prevention and Treatment of HIV Infection US 60/124,681 Abandoned
NICHD E-286-1998-0-US-01 Prevention of Fetal Alcohol Syndrome and Neuronal Cell Death With ADNF Polypeptides US ORD 09/267,511 6933277 Abandoned PDF
NCI E-057-1994-2-US-03 MELANOMA ANTIGENS [MART-1 only] AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 09/267,439 6270778 Expired PDF
NCI E-107-1998-0-PCT-02 METHODS AND COMPOSITIONS OF CHEMOKINE-TUMOR ANTIGEN FUSION PROTEINS AS CANCER VACCINES PCT PCT PCT/US1999/005345 Expired
NCI E-074-1999-0-US-01 Cyanovirin Conjugates And Matrix-Anchored Cyanovirin And Related Compositions And Methods of Use US CIP 09/267,447 Abandoned
NCI E-037-1999-0-US-01 Hydrazide Inhibitors of HIV-1 Integrase US 60/124,302 Abandoned
NIAID E-103-1999-0-US-01 Identification and Use of High Efficacy Vaccine Antigens US 60/124,064 Abandoned
NCI E-084-1999-0-US-01 Methods for Inhibiting Chaperone Proteins US 60/124,135 Abandoned
NICHD E-068-1999-0-US-01 UPA, A Universal Protein Array System for Quantitative Detection of Protein Interactions With Protein, DNA, RNA, and Ligands US 60/123,586 Abandoned
NIMH E-121-1999-0-US-01 Displacement of a Defective Mitochondrial DNA Gene Product by a Nondefective Gene Product of the Nuclear Genome US 60/123,336 Abandoned
NHLBI E-274-1998-0-US-01 Chromatographic Separation Apparatus and Method US ORD 09/263,609 6379973 Abandoned PDF
NCI E-244-1997-1-US-01 Novel Vacuolar (H+)-ATPase-Inhibitory Compositions and Uses Thereof US 60/122,953 Abandoned
NIDDK E-023-1996-2-US-02 Method of Treating Ischemic, Hypoxic And Anoxic Brain Damage US National Stage 09/155,931 6316423 Abandoned PDF
NCI E-194-1989-0-US-05 RNA Probe for Detecting c-fes mRNA US DIV 09/262,792 6232069 Expired PDF
NIAID E-004-2004-0-US-01 Anti-Plasmodium Antibodies And Methods Of Use US 60/122,842 Abandoned
NCI E-093-1996-3-US-06 O2-ARYLATED AND O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2- DIOLATES AND 02-SUBSTITUTED 1-[(2-CARBOXYLATO)PYROLIDIN-1-YL]... US National Stage 09/254,301 6610660 Expired PDF
NCI E-303-1998-0-US-01 Water-Soluble Derivatives of Camptothecin/Homocampothecin US 60/122,621 Abandoned
NIDDK E-253-1999-1-US-01 Methods for Treating Glaucoma US 60/122,965 Abandoned
NCI E-290-1997-0-CA-05 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS CA National Stage 2321962 Abandoned
NCI E-290-1997-0-DE-07 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS DE EP 99908589.7 Abandoned
NCI E-290-1997-0-FR-09 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS FR EP 99908589.7 Abandoned
NCI E-290-1997-0-EP-04 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS EP National Stage 99908589.7 Abandoned
NCI E-290-1997-0-ES-08 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS ES EP 99908589.7 Abandoned
NCI E-290-1997-0-GB-10 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS GB EP 99908589.7 Abandoned
NCI E-290-1997-0-IT-11 G-PROTEIN-COUPLED RECEPTOR ANTAGONISTS IT EP 99908589.7 Abandoned
NCI E-086-1999-0-US-01 Nucleic Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of Reagents Derived from These Sequences In the Diagnosis of Disseminated Cadida Albicans Infections US ORD 09/258,634 6875855 Abandoned PDF